Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches
Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.
Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks
Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to support your study requirements with read-ready functionality quickly available.
Multiple read paradigms: Support for single reads, double reads with adjudication, and eligibility workflows
Multi-criteria reads: Apply multiple evaluation frameworks to the same image
Flexible templates: Use standard response criteria read templates or custom eCRFs you design
Built-in analytics: Volumetrics, SUVs, tumor growth rates, and radiomics capabilities
Automated notifications: Alerts configured to align with your review flow
Export functionality: One-click exports for images, data (CDISC, radiomics, observations), and structured results
Related Resources
Related Resources
Prof. Dr. Philippe Pereira
It was a sensation for our clinical colleagues to discover the report made with mint Lesion™, which is able to present all the clinical and…
Dr. Remy Geenen
By using mint Lesion™, we are able to generate standardized, complete and consistent oncologic reports. Not only can we describe all the important…
Prof. Dr. Werner Jaschke
mint Lesion™ offers an integrated solution that combines documented findings from the radiologist with structured reporting for other clinicians in a…
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.